Segment disclosures

Company overview

Scienture Holdings, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

14 dimension combinations 111 retained observations 25 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Community Specialty Pharmacy LLC

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:CommunitySpecialtyPharmacyLLCMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-06-30637068 USD20230818Open filing evidence
2023-01-01 – 2023-03-31311257 USD20230515Open filing evidence
2022-01-01 – 2022-12-311175474 USD20230418Open filing evidence
2022-01-01 – 2022-09-30905083 USD20221128Open filing evidence
2022-01-01 – 2022-06-30563943 USD20230818Open filing evidence
2022-01-01 – 2022-03-31268407 USD20230515Open filing evidence
2021-01-01 – 2021-12-311652841 USD20230418Open filing evidence
2021-01-01 – 2021-09-301287296 USD20221128Open filing evidence
2021-01-01 – 2021-06-30832243 USD20220725Open filing evidence
2021-01-01 – 2021-03-31397896 USD20220509Open filing evidence
2020-01-01 – 2020-12-311653924 USD20221128Open filing evidence

Integra

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:IntegraMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-3018699 USD20240809Open filing evidence
2024-01-01 – 2024-06-3018699 USD20240809Open filing evidence
2023-01-01 – 2023-12-311363830 USD20240422Open filing evidence
2023-04-01 – 2023-06-30366526 USD20240809Open filing evidence
2023-01-01 – 2023-06-30842882 USD20240809Open filing evidence
2023-01-01 – 2023-03-31476356 USD20240626Open filing evidence
2022-01-01 – 2022-12-314754067 USD20240422Open filing evidence

Integra Pharma LLC

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:IntegraPharmaLLCMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-06-30842882 USD20230818Open filing evidence
2023-01-01 – 2023-03-31476356 USD20230515Open filing evidence
2022-01-01 – 2022-12-314754067 USD20230418Open filing evidence
2022-01-01 – 2022-09-303949772 USD20221128Open filing evidence
2022-01-01 – 2022-06-303241965 USD20230818Open filing evidence
2022-01-01 – 2022-03-311567530 USD20230515Open filing evidence
2021-01-01 – 2021-12-313250561 USD20230418Open filing evidence
2021-01-01 – 2021-09-302511270 USD20221128Open filing evidence
2021-01-01 – 2021-06-301715466 USD20220725Open filing evidence
2021-01-01 – 2021-03-311402586 USD20220509Open filing evidence
2020-01-01 – 2020-12-319877067 USD20221128Open filing evidence

IPS

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:IPSMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-301237731 USD20240116Open filing evidence
2022-01-01 – 2022-09-303949772 USD20240116Open filing evidence

Superlatus

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:SuperlatusMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31487021 USD20240422Open filing evidence

Trxade Inc

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:TrxadeIncMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-316402159 USD20240422Open filing evidence
2023-01-01 – 2023-09-304663756 USD20240116Open filing evidence
2023-01-01 – 2023-06-303000020 USD20230818Open filing evidence
2023-01-01 – 2023-03-311443177 USD20230515Open filing evidence
2022-01-01 – 2022-12-315435814 USD20240422Open filing evidence
2022-01-01 – 2022-09-304001670 USD20240116Open filing evidence
2022-01-01 – 2022-06-302664237 USD20230818Open filing evidence
2022-01-01 – 2022-03-311381963 USD20230515Open filing evidence
2021-01-01 – 2021-12-314924015 USD20230418Open filing evidence
2021-01-01 – 2021-09-303653269 USD20221128Open filing evidence
2021-01-01 – 2021-06-302387360 USD20220725Open filing evidence
2021-01-01 – 2021-03-311236650 USD20220509Open filing evidence
2020-01-01 – 2020-12-315546746 USD20221128Open filing evidence

Unallocated Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=MEDS:UnallocatedSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3116960 USD20240626Open filing evidence

Integra

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=SCNX:IntegraMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3110258 USD20250512Open filing evidence
2024-01-01 – 2024-12-31136643 USD20250326Open filing evidence
2024-07-01 – 2024-09-3064861 USD20241106Open filing evidence
2024-01-01 – 2024-09-3083560 USD20241106Open filing evidence
2023-01-01 – 2023-12-311363830 USD20250326Open filing evidence
2023-07-01 – 2023-09-30392286 USD20241106Open filing evidence
2023-01-01 – 2023-09-301235168 USD20241106Open filing evidence

Community Specialty Pharmacy LLC

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=TRXD:CommunitySpecialtyPharmacyLLCMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-09-301287296 USD20211025Open filing evidence
2021-01-01 – 2021-06-30832243 USD20210726Open filing evidence
2021-01-01 – 2021-03-31397896 USD20210426Open filing evidence
2020-01-01 – 2020-12-311653924 USD20210329Open filing evidence
2020-01-01 – 2020-09-301287197 USD20211025Open filing evidence
2020-01-01 – 2020-06-30870637 USD20210726Open filing evidence
2020-01-01 – 2020-03-31432929 USD20210426Open filing evidence
2019-01-01 – 2019-12-311888086 USD20210329Open filing evidence
2019-01-01 – 2019-09-301412449 USD20201026Open filing evidence
2019-01-01 – 2019-06-30892357 USD20200727Open filing evidence
2019-01-01 – 2019-03-31442423 USD20200504Open filing evidence
2018-01-01 – 2018-12-31395418 USD20200330Open filing evidence

Integra Pharma LLC

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=TRXD:IntegraPharmaLLCMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-09-302511270 USD20211025Open filing evidence
2021-01-01 – 2021-06-301715466 USD20210726Open filing evidence
2021-01-01 – 2021-03-311402586 USD20210426Open filing evidence
2020-01-01 – 2020-12-319877067 USD20210329Open filing evidence
2020-01-01 – 2020-09-309548512 USD20211025Open filing evidence
2020-01-01 – 2020-06-305003523 USD20210726Open filing evidence
2020-01-01 – 2020-03-31245016 USD20210426Open filing evidence
2019-01-01 – 2019-12-311020438 USD20210329Open filing evidence
2019-01-01 – 2019-09-30992862 USD20201026Open filing evidence
2019-01-01 – 2019-06-30353910 USD20200727Open filing evidence
2019-01-01 – 2019-03-3126288 USD20200504Open filing evidence
2018-01-01 – 2018-12-3128538 USD20200330Open filing evidence

Other

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=TRXD:OtherMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-06-30353910 USD20191015Open filing evidence
2019-01-01 – 2019-03-3126288 USD20190513Open filing evidence
2018-01-01 – 2018-12-3128538 USD20191217Open filing evidence

Other Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=TRXD:OtherSegmentsMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-09-3023898 USD20201026Open filing evidence
2020-01-01 – 2020-06-307260 USD20200727Open filing evidence
2020-01-01 – 2020-03-315468 USD20200504Open filing evidence

Trxade Inc

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=TRXD:TrxadeIncMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-09-303653269 USD20211025Open filing evidence
2021-01-01 – 2021-06-302387360 USD20210726Open filing evidence
2021-01-01 – 2021-03-311236650 USD20210426Open filing evidence
2020-01-01 – 2020-12-315546746 USD20210329Open filing evidence
2020-01-01 – 2020-09-304268619 USD20211025Open filing evidence
2020-01-01 – 2020-06-302914537 USD20210726Open filing evidence
2020-01-01 – 2020-03-311519907 USD20210426Open filing evidence
2019-01-01 – 2019-12-314527740 USD20210329Open filing evidence
2019-01-01 – 2019-09-303335050 USD20201026Open filing evidence
2019-01-01 – 2019-06-302182668 USD20200727Open filing evidence
2019-01-01 – 2019-03-311043810 USD20200504Open filing evidence
2018-01-01 – 2018-12-313407822 USD20200330Open filing evidence

All Other Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3119204 USD20240422Open filing evidence
2023-01-01 – 2023-09-3018299 USD20240116Open filing evidence
2023-01-01 – 2023-06-3018856 USD20230818Open filing evidence
2023-01-01 – 2023-03-3116960 USD20230515Open filing evidence
2022-01-01 – 2022-12-3160287 RestatedUSD20240422Open filing evidence
2022-01-01 – 2022-09-3042363 RestatedUSD20240116Open filing evidence
2022-01-01 – 2022-06-3048856 USD20230818Open filing evidence
2022-01-01 – 2022-03-3122372 USD20230515Open filing evidence
2021-01-01 – 2021-12-3162016 USD20230418Open filing evidence
2021-01-01 – 2021-09-3049700 USD20221128Open filing evidence
2021-01-01 – 2021-06-3016420 USD20220725Open filing evidence
2021-01-01 – 2021-03-3116103 USD20220509Open filing evidence
2020-01-01 – 2020-12-3144783 USD20221128Open filing evidence
2020-01-01 – 2020-09-3023898 USD20211025Open filing evidence
2020-01-01 – 2020-06-307260 USD20210726Open filing evidence
2020-01-01 – 2020-03-315468 USD20210426Open filing evidence